XRP is sliding again after a brutal crypto sell-off wiped out over $600 million in leveraged trades.XRP is sliding again after a brutal crypto sell-off wiped out over $600 million in leveraged trades.

Will XRP Price Crash Further or Rebound Soon?

XRP price is struggling to regain balance after a sharp sell-off that mirrored the broader crypto market’s turbulence. Over $640 million in leveraged positions were wiped out in 24 hours, turning a typical weekend correction into a cascading liquidation event. Bitcoin’s plunge below $86,000 triggered panic across altcoins, and XRP was no exception — dropping about 4% in the latest session to trade around $2.09. The question now is whether XRP’s decline is nearing exhaustion or just beginning another leg down.

XRP Price Prediction: Price Fights the Midline of Bollinger Bands

XRP Price PredictionXRP/USD Daily Chart- TradingView

The daily chart shows XRP price trading below the 20-day moving average (blue line) and clinging to the mid-zone of the Bollinger Bands. This setup typically signals ongoing bearish control, especially when candles close beneath the middle band. The recent rejection near $2.18 suggests the bulls are struggling to flip that level into support.

The Bollinger Bands are moderately contracted, indicating that volatility might compress before another directional move. A close below $2.04 — the lower range of recent consolidation — could invite deeper selling pressure, pushing XRP price toward $1.85 or even $1.65, where the next Fibonacci retracement supports align. Conversely, reclaiming $2.20 could signal the start of a short-term rebound toward $2.40, but momentum indicators still favor the bears.

Macro Headwinds: Rising Yields and Risk-Off Sentiment

Outside the charts, macro signals continue to weigh on crypto sentiment. Japan’s 10-year bond yield climbing to 1.84% — its highest since 2008 — hints at a global shift in liquidity preferences. Investors are moving back into traditional assets like gold, which gained 0.58% while Bitcoin and altcoins suffered broad losses. The strong correlation between crypto and the Nasdaq (0.83 on a 7-day basis) also means that any equity pullback could further drag XRP and other risk assets down.

Derivative Market Stress: High Leverage Magnifies Losses

Liquidations are another red flag. With open interest hovering around $771 billion, the market remains dangerously over-leveraged. This setup amplifies volatility — even minor dips can trigger forced selling, as seen during the recent cascade. XRP, being a high-beta altcoin, often bears the brunt of these liquidations, exaggerating its price swings.

XRP Price Prediction: Cautious Short-Term, Opportunity Mid-Term

Technically and sentiment-wise, XRP price still faces downside risk in the near term. A decisive breakdown below $2.00 could accelerate losses toward $1.80. Yet, with RSI approaching oversold levels and the broader market showing signs of exhaustion, a relief rally isn’t off the table. Medium-term investors may look for accumulation zones between $1.65 and $1.85 if Bitcoin stabilizes above $85K.

In short, while $XRP may see more pain before recovery, panic selling is already showing signs of cooling. Whether the coin rebounds or continues sliding will depend heavily on Bitcoin’s ability to reclaim lost ground — and on whether macro risks ease before December’s key Fed decision.

Market Opportunity
XRP Logo
XRP Price(XRP)
$2.0639
$2.0639$2.0639
-1.55%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23